Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
- Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community.
- You can reach Angus on Signal at angus.08.
- So-called “neoantigen” vaccines have long been seen as having potential as
Unverified
- Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community.
- You can reach Angus on Signal at angus.08.
- So-called “neoantigen” vaccines have long been seen as having potential as
Sources: Statnews